fexofenadine/Allegra (M016455)

DRUG2 trials

Sponsors

Sanofi

Conditions

Atopic DermatitisRhinitis Perennial

Phase 2

Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Perennial Allergic Rhinitis (PAR)

CompletedNCT01244217

SanofiRhinitis Perennial

Start: 2010-10-31End: 2011-08-31Updated: 2013-10-16

Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)

CompletedNCT01244230

SanofiAtopic Dermatitis

Start: 2010-11-30End: 2011-08-31Updated: 2013-10-16